Recruiting Clinical Trials

Displaying 1 - 10 of 238 result(s)
Study Title Condition Phase Location
A Non-interventional Study Evaluating Kesimpta® (Ofatumumab) Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies [KAIROS] Multiple Sclerosis Not Given
  • Country: 
    Germany
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients (Prevention of Relapses and Delay of Progression of Physical Disability in Secondary Progressive Multiple Sclerosis) Secondary Progressive Multiple Sclerosis (SPMS) Not Given
  • Country: 
    Japan
A Multi-center, Randomized, Double-blind, Parallel-group, 20-week Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of XXB750 in Patients With Resistant Hypertension Resistant Hypertension Phase 2
  • Country: 
    United States
  • Country: 
    Australia
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients IgA Nephropathy Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
    More locations
Special Drug Use-results Surveillance of Tabrecta Tablets (MET Exon 14 Skipping Mutation-positive Unresectable Advanced/Recurrent Non-small Cell Lung Cancer) Non-small Cell Lung Cancer Not Given
  • Country: 
    Japan
A Randomized, Controlled, Multicenter, Open-label Trial Comparing a Hospital Post-discharge Care Pathway Involving Aggressive LDL-C Management That Includes Inclisiran With Usual Care Versus Usual Care Alone in Patients With a Recent Acute Coronary S ... Acute Coronary Syndrome Phase 3
  • Country: 
    United States
AcTION: A Phase I Study of [225Ac]Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer With or Without Prior [177Lu]Lu-PSMA-617 Radioligand Therapy Prostatic Neoplasms, Castration-Resistant Phase 1
  • Country: 
    Australia
  • Country: 
    South Africa
A Randomized, Subject and Investigator Blinded, Placebo-controlled and Multi-center Platform Study, to Assess Efficacy and Safety of Different Investigational Drugs in Patients With Moderate to Severe Hidradenitis Suppurativa Hidradenitis Suppurativa Phase 2
  • Country: 
    United States
  • Country: 
    Austria
  • Country: 
    Belgium
  • Country: 
    More locations
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting (VICTORION-Implement) Hypercholesterolemia Not Given
  • Country: 
    Germany
Efficacy, Safety, Tolerability and Quality of Life of Ongoing Individually Optimized Lipid-lowering Therapy With or Without Inclisiran (KJX839) - a Randomized, Placebo-controlled, Double-blind Multicenter Phase IV Study in Participants With Hyperchol ... Hypercholesterolemia Phase 4
  • Country: 
    Bulgaria
  • Country: 
    Czech Republic
  • Country: 
    Estonia
  • Country: 
    More locations